Key Takeaways
- Propranolol 10–40 mg taken 30–60 minutes before an event is the established off-label treatment for situational performance anxiety — it blocks peripheral sympathetic symptoms without dulling the mind.
- Beta-blockers work at the body's periphery: they prevent adrenaline from triggering tremor, tachycardia, sweating, and dry mouth — the physical loop that worsens cognitive anxiety.
- Propranolol is preferred over benzodiazepines for performance anxiety because it does not cause sedation, cognitive dulling, or dependence risk at the doses used.
- Situational performance anxiety and social anxiety disorder are distinct diagnoses that require different treatment strategies — the distinction matters clinically.
- CBT is first-line for generalized social anxiety disorder; SSRIs and SNRIs are first-line medications for SAD. Propranolol alone is not appropriate for SAD.
- Propranolol is contraindicated in asthma, significant bradycardia, and decompensated heart failure — a physician review is required before prescribing.
Heart pounding before a presentation. Hands shaking during an audition. Voice wavering right when you need it steady. Millions of people experience performance anxiety, and many don't realize there's a well-established, low-risk medication that can quiet those physical symptoms in under an hour.
Propranolol for situational performance anxiety has been used by musicians, public speakers, surgeons, and test-takers for decades. It is off-label, but the evidence is solid and the clinical experience is extensive. In my practice, it's one of the most straightforward prescribing decisions I make — when the clinical picture is right.
That last part matters. "When the clinical picture is right" means a physician has confirmed you're dealing with situational anxiety rather than a broader anxiety disorder, has checked for contraindications, and has determined that a beta-blocker is the appropriate tool. This guide covers all of that — the pharmacology, the evidence, the diagnostic distinctions, and the full treatment spectrum from medication to therapy.
What Is Performance Anxiety?
Performance anxiety is the experience of significant physical and psychological distress triggered by the anticipation or execution of a public performance or evaluation. The fear centers on being observed, judged, or failing — and the body's stress response kicks in whether or not the threat is real.
The term covers several distinct contexts, each with slightly different clinical features:
- Public speaking anxiety: The most common form, affecting an estimated 25–75% of the general population to some degree. Symptoms range from mild nervousness to full freeze responses.
- Musical performance anxiety (MPA): Particularly well-studied. Among professional orchestral musicians, surveys have found that 16–59% report significant performance anxiety, with instrumentalists more affected than singers.[1]
- Test and exam anxiety: Triggered by high-stakes academic or professional evaluations. The cognitive overlay — fear of failure, mind-blanking — often compounds the physical symptoms.
- Athletic performance anxiety: Affects athletes at competitive events, particularly in precision or individual sports. Relevant not only to subjective performance but to injury risk under impaired motor control.
- Sexual performance anxiety: Situational anxiety that interferes with sexual function — a distinct presentation requiring thoughtful evaluation, as medical and psychological contributors overlap.
- Professional performance anxiety: Surgeons, presenters, job interviewers — any high-stakes professional task where being observed raises anxiety and impairs precision.
What unites these presentations is the mechanism: stress hormones — primarily epinephrine (adrenaline) and norepinephrine — flood the system and activate beta-adrenergic receptors throughout the body. The result is the classic fight-or-flight cascade, deployed at exactly the wrong moment.
Social Anxiety Disorder vs. Situational Performance Anxiety
This distinction is one of the most clinically important concepts in this guide. It determines whether propranolol PRN is the right answer — or whether a different treatment plan is needed entirely.
Situational Performance Anxiety
Situational performance anxiety is triggered by specific, discrete performance events. Between these events, there is no significant anxiety about social interactions. You can have a conversation, attend a party, or eat in a restaurant without distress. The anxiety is event-specific and context-specific. When the event is over, it resolves.
This is the population for whom propranolol PRN is designed. The clinical logic is clean: you know when the triggering event occurs, you take the medication in advance, the physical symptoms are controlled, and there is no ongoing psychological burden between events.
Social Anxiety Disorder (SAD)
Social anxiety disorder is a chronic condition defined in the DSM-5 as a marked, persistent fear of social situations where the person fears being scrutinized, embarrassed, or humiliated by others.[3] The fear spans multiple domains of social life — not just formal performances but everyday interactions, eating in public, meeting new people, or being observed doing routine tasks. To meet diagnostic criteria, the anxiety must be disproportionate to the actual threat, persistent for at least six months, and cause clinically significant distress or impairment.[3]
The DSM-5 does include a "performance only" specifier for SAD — applied when the fear is restricted specifically to public speaking or performing. This is not the same as situational performance anxiety in the everyday sense. The key clinical question is whether the anxiety causes significant ongoing impairment and meets the full DSM criteria, or whether it is better characterized as a normal (if uncomfortable) situational stress response.
| Feature | Situational Performance Anxiety | Social Anxiety Disorder |
|---|---|---|
| Trigger | Specific performance events (speech, recital, exam) | Broad range of social interactions and observation situations |
| Baseline anxiety | Low to absent between events | Persistent anxiety, avoidance, anticipatory worry in daily life |
| Functional impairment | Limited to performance contexts | Significant across occupational, social, and personal domains |
| Duration | Event-specific; resolves after performance | Persistent; typically >6 months by diagnostic criteria |
| First-line treatment | Propranolol PRN; CBT optional for cognitive symptoms | CBT (first-line therapy); SSRIs/SNRIs (first-line medications) |
A patient with social anxiety disorder who takes propranolol before a presentation may see their heart rate slow — but they will still ruminate about the presentation for weeks beforehand, dissect their performance afterwards, and struggle with the dozens of other social situations that trigger their anxiety every week. Propranolol PRN does not treat the underlying disorder. SSRIs, SNRIs, and CBT do. Misidentifying the diagnosis leads to undertreated SAD and wasted time.
How Propranolol Works: The Beta-Blocker Mechanism
Propranolol is a non-selective beta-adrenergic receptor antagonist — meaning it blocks both beta-1 receptors (found primarily in the heart) and beta-2 receptors (found in the lungs, blood vessels, and peripheral tissues).[2] For performance anxiety, the key is what happens at the periphery.
When you're anxious, your adrenal glands release epinephrine and norepinephrine. These stress hormones bind to beta receptors throughout the body and produce the recognizable symptoms of acute anxiety:
- Beta-1 activation in the heart → tachycardia (racing pulse), increased contractility
- Beta-2 activation in skeletal muscle → tremor, fine motor instability
- Beta-2 activation in sweat glands and peripheral vessels → sweating, flushing
- Autonomic activation → dry mouth, nausea, GI distress
Propranolol competitively blocks these receptors before epinephrine can bind. The physical cascade never fully fires. Your hands stay steady. Your voice doesn't waver. Your heart rate stays controlled. The stage is literally no longer frightening your body — even if your mind still knows the stakes are high.[1]
Beta-blocking agents used for performance anxiety act predominantly at the periphery. What I tell my patients is this: propranolol doesn't make you feel calm. It removes the physical signals that your brain was using to decide you were in danger. Once those signals stop, the cognitive spiral often quiets on its own — because the feedback loop between body and mind gets interrupted.
Physical anxiety symptoms don't just accompany the fear — they amplify it. A performer notices their hands shaking, which makes them more anxious, which worsens the tremor, which compounds the cognitive disruption. By breaking this physical feedback loop at the receptor level, propranolol interrupts the cycle before it escalates. This is why musicians describe improved performance quality after propranolol — not because the drug gives them skill, but because it removes the physiological interference that was degrading skill they already had.[1]
Propranolol Dosing for Performance Anxiety
For situational performance anxiety, propranolol is dosed on an as-needed (PRN) basis — taken only before specific events that trigger symptoms. This is not a daily medication in this context, and PRN use does not lead to dependence.
Standard Dosing Range: 10–40 mg
The typical starting dose is 10–20 mg, taken 30–60 minutes before the performance event. Some patients require 40 mg for adequate symptom control. The dosing range in the published literature spans from 10 mg to 80 mg depending on individual physiology, but the 10–40 mg range covers the vast majority of clinical use in healthy adults.[2]
| Dosing Parameter | Details |
|---|---|
| Typical dose range | 10–40 mg orally PRN |
| Timing | 30–60 minutes before the event; propranolol reaches peak plasma concentration approximately 60–75 minutes after oral intake |
| Starting dose | 10–20 mg; titrate based on response and tolerability |
| Duration of action | Approximately 3–6 hours — shorter than benzodiazepines, which is often preferable for event-specific use |
| FDA approval status | Off-label for performance anxiety; FDA-approved for hypertension, angina, arrhythmia, migraine prophylaxis, essential tremor |
| Trial dose recommendation | Always take a test dose before the actual event to assess response and check for unexpected side effects |
One practical point I emphasize to every patient: always take your first dose in a low-stakes setting before using it for the actual performance. A small number of people experience more bradycardia than expected, lightheadedness, or fatigue at a given dose. You want to discover that before the audition, not during it.
The Evidence Base for Propranolol in Performers
The research on propranolol for performance anxiety goes back more than five decades, with some landmark studies setting the foundation for current clinical practice.
Brantigan et al. (1982) — The Musician Study
One of the most cited studies in this area involved 29 musicians in a double-blind, crossover design. Propranolol was given 1.5 hours before recitals on two successive days. The results were striking: performers preferred propranolol over placebo across every measured category — nervousness, anxiety, tremor, sweating, accuracy, style, control, tempo, rhythm, and comfort. Music critics rated the performances as significantly better after propranolol. Heart rate was reduced during performances, and participants did not report cognitive impairment.[1]
Faigel (1991) — SAT Performance
In an open-label study of 32 high school students taking the SAT, a single 40 mg dose of propranolol one hour before the exam produced a mean improvement in SAT verbal score of 50 points and math score of 80 points, both statistically significant. While this was an uncontrolled trial, the signal was consistent with the hypothesis that physiological anxiety was impairing performance that propranolol then freed.[1]
Elman et al. (1998) — Surgical Performance
In a blinded crossover study, ophthalmology residents performed surgery after taking either 40 mg propranolol or placebo one hour prior. Propranolol significantly reduced both anxiety and surgical tremor — without any impairment of higher cognitive function. The study is notable because it demonstrates efficacy in a setting where both physical precision and mental clarity are simultaneously required.[6]
Propranolol vs. Diazepam — Head-to-Head Data
A study by Albus et al. found that 40 mg propranolol was more effective than 10 mg diazepam and isamoltane in reducing excessive heart rate, elevated norepinephrine levels, and blood pressure under stress conditions. Crucially, in a separate double-blind crossover study, a high dose of lorazepam impaired performance and increased dizziness, while propranolol did not. Lorazepam also increased sedation ratings; propranolol did not. Propranolol decreased pulse; lorazepam increased it.[1]
Propranolol vs. Benzodiazepines: Why Beta-Blockers Win for This Indication
Benzodiazepines — diazepam, lorazepam, alprazolam — are effective anxiolytics, but they are generally the wrong tool for situational performance anxiety. The comparison matters because patients sometimes arrive having been prescribed, or having sourced, a benzodiazepine for their performance anxiety.
| Property | Propranolol (Beta-Blocker) | Benzodiazepines |
|---|---|---|
| Mechanism | Blocks peripheral beta-adrenergic receptors; interrupts physical anxiety response | Enhances GABA activity in the central nervous system; broadly sedating |
| Effect on cognition | No cognitive dulling at doses used for performance anxiety | Causes sedation, impairs memory formation, slows reaction time |
| Effect on physical symptoms | Directly targets tremor, tachycardia, sweating — the core physical symptoms | Physical symptoms may reduce secondarily through general sedation |
| Dependence risk | None at PRN doses used for performance anxiety | Significant; physical dependence can develop with regular use; discontinuation syndrome is clinically serious |
| Onset of action | 30–60 minutes | 15–60 minutes depending on agent |
| Duration | 3–6 hours (favorable for event-specific use) | Varies widely: 4–6 hours to more than 24 hours depending on agent |
| Performance impairment | Minimal to none in studies; surgical and musical performance preserved or improved | Demonstrated performance impairment at anxiolytic doses |
| Appropriate for SAD? | No — does not treat the underlying disorder | No for ongoing use; may be second-line for acute management of SAD |
The clinical bottom line: for a musician, speaker, or surgeon who needs to remain mentally sharp and physically steady, propranolol preserves the cognitive function that benzodiazepines impair. This is not a close call for performance-specific indications.[7]
Contraindications: Who Should Not Take Propranolol
- Asthma or a history of bronchospasm — propranolol blocks beta-2 receptors in the airways, which can precipitate life-threatening bronchoconstriction in asthmatics. This is an absolute contraindication, not a caution.
- Significant bradycardia — resting heart rate below 60 bpm. Propranolol will further slow the heart, potentially causing symptomatic bradycardia or hemodynamic compromise.
- Decompensated heart failure — uncontrolled or actively symptomatic heart failure. Beta-blockers can worsen cardiac output in this setting.
- Cardiogenic shock — propranolol's negative inotropic effects are dangerous in cardiogenic shock.
- Greater than first-degree heart block — risk of complete heart block and cardiac arrest.
- Known hypersensitivity to propranolol
Relative Contraindications: Caution Required
- COPD: Not an absolute contraindication, but propranolol's non-selective beta-2 blockade worsens airway function. If a beta-blocker is needed in a patient with COPD, a cardioselective agent (metoprolol, bisoprolol) is preferred.[2]
- Diabetes mellitus: Propranolol can mask the tachycardia and tremor that normally signal hypoglycemia. Patients with insulin-dependent diabetes or difficult glucose control require careful discussion before prescribing.
- Low blood pressure: Propranolol further lowers blood pressure. In patients with baseline hypotension, this may cause dizziness or syncope.
- Peripheral vascular disease: Beta-2 blockade causes mild vasoconstriction; patients with Raynaud's phenomenon or significant peripheral arterial disease may experience worsening symptoms.
- Concurrent calcium channel blocker use (verapamil or diltiazem): Additive negative inotropic and chronotropic effects — this combination can precipitate cardiogenic shock.
Disclosing your full medical history during a physician evaluation is not a formality. These are real contraindications with real consequences. A brief telehealth consult that confirms the absence of contraindications takes minutes and makes this prescribing decision safe.
Treating Social Anxiety Disorder: A Different Pathway
If the clinical picture points toward social anxiety disorder rather than situational performance anxiety, the treatment plan changes substantially. Propranolol PRN is not a treatment for SAD — it addresses one dimension of a broader, chronic disorder.
Cognitive Behavioral Therapy (CBT): First-Line
CBT is the most well-supported psychological treatment for social anxiety disorder. It works by identifying and restructuring the distorted beliefs and cognitive patterns that drive social anxiety — catastrophizing about negative evaluation, overestimating the probability of humiliation, and underestimating one's ability to cope. Standard CBT protocols for SAD involve 12–20 weekly sessions.
What CBT does that propranolol cannot: it changes the underlying appraisal of threat. A performer who completes CBT doesn't just have controlled symptoms on the day of performance — they genuinely evaluate the performance situation differently. The effect is durable in a way that PRN medication is not. For patients with SAD, this durability matters enormously.[4]
SSRIs and SNRIs: First-Line Medications for SAD
FDA-approved medications for social anxiety disorder include the SSRIs paroxetine and sertraline, and the SNRI venlafaxine. Escitalopram and fluvoxamine are also frequently used off-label for SAD with strong evidence.[4] These medications work by modulating serotonin and norepinephrine signaling in anxiety circuits, and they require 4–8 weeks of consistent daily dosing before full benefit is realized.
SSRIs and SNRIs are fundamentally different from propranolol in their scope: they treat the chronic, pervasive anxiety that defines SAD, not the acute physical symptoms of a specific event. Patients starting an SSRI for SAD are not taking a pill before each presentation — they are treating an underlying anxiety disorder that affects their daily life.
Exposure Therapy
Exposure therapy — systematic, graduated exposure to feared social situations — is often integrated into CBT protocols for SAD. The principle is straightforward: anxiety decreases through repeated, controlled confrontation with the feared stimulus. For a patient with performance anxiety in the context of SAD, this might involve a hierarchy of speaking tasks, starting with low-stakes situations and progressively approaching more challenging ones. Without exposure, the avoidance that characterizes SAD becomes self-reinforcing.
Combination Approaches
For patients with social anxiety disorder, the combination of SSRIs or SNRIs plus CBT tends to produce better outcomes than either alone. Research has consistently shown that SSRI combined with CBT leads to more responders and better long-term results compared to CBT plus placebo, with superior symptom reduction sustained at 15 months follow-up.[5]
For a patient with SAD who also has specific, high-stakes performance events — a conference presentation, a major audition — there may be a role for propranolol PRN as an adjunct to their primary SAD treatment. The key word is adjunct. Propranolol in this context is a tool for a specific event, not a substitute for treating the underlying disorder.
When Medication Alone Is Not Enough
Propranolol controls the physical dimension of performance anxiety reliably and well. But performance anxiety is not a purely physical problem for everyone. Some performers find that even with zero tremor and a controlled heart rate, the cognitive and emotional experience of anxiety remains disabling.
Signs that medication alone is insufficient:
- You take propranolol, physical symptoms are controlled, but significant anxiety and negative self-talk persist during performance
- You avoid performances entirely despite having access to medication
- Anticipatory anxiety in the days or weeks before an event is causing significant distress
- The anxiety is impairing preparation — you cannot practice effectively because of anxiety about the upcoming event
- Performance anxiety is expanding to affect more situations over time
Any of these patterns suggests that the cognitive and behavioral components of anxiety warrant attention through therapy. CBT or exposure therapy targeting performance-specific fear schemas can produce durable changes that medication alone won't provide. In practice, the best outcomes I see in performers are those who use propranolol for acute symptom control while working with a therapist on the cognitive architecture of their anxiety.
Telehealth Prescribing for PRN Propranolol
Situational performance anxiety is well-suited to telehealth prescribing. The clinical evaluation is primarily history-based: symptoms, triggers, frequency, baseline heart rate, contraindication screening. There is no physical exam finding that changes the prescribing decision for a healthy adult with isolated performance anxiety.
What a telehealth visit for performance anxiety should include:
- Detailed symptom history — what triggers anxiety, which symptoms predominate, frequency of events
- Medical history review — specifically screening for asthma, COPD, cardiac arrhythmias, bradycardia, heart failure, and diabetes
- Current medications — particularly checking for calcium channel blockers, other antihypertensives, and any medications with known interactions
- Diagnostic assessment — confirming situational performance anxiety rather than SAD, panic disorder, or another anxiety condition requiring different management
- Baseline vital signs — patients with access to a home blood pressure cuff can provide resting heart rate and blood pressure, which is helpful for dose selection
- Dosing guidance — including the recommendation to trial the dose before the actual event
Obtaining beta-blockers for anxiety through a legitimate, HIPAA-compliant telehealth platform that requires an evaluation by a licensed healthcare provider is safe and appropriate. The telehealth model genuinely improves access to care here — many patients who would benefit from this medication simply won't schedule an in-person appointment for what feels like a "minor" issue, even when the impact on their professional and personal life is significant.
Avoid any platform that offers prescription medications without a clinician evaluation. The contraindication screen is not optional — it is what makes this safe.
At TeleDirectMD, our physicians evaluate performance anxiety patients across 35+ licensed states via secure video visit. Phone: 678-956-1855 | Email: contact@teledirectmd.com
Frequently Asked Questions
The standard dose range is 10–40 mg taken 30–60 minutes before the event. Most patients start at 10–20 mg. A physician should determine your starting dose based on your baseline heart rate, blood pressure, and medical history. Always trial the dose in a low-stakes setting before the actual performance.
No. At the low doses used for performance anxiety, propranolol works primarily at the body's periphery — it quiets physical symptoms without sedating the brain. Multiple controlled studies in musicians, students, and surgeons found no impairment of cognitive function, verbal reasoning, or mental arithmetic. You stay sharp; the shaking and racing heart simply stop.
Situational performance anxiety is triggered by specific events — a speech, audition, or exam — with minimal anxiety outside those contexts. Social anxiety disorder is a chronic condition involving persistent, pervasive fear of being judged across many social situations, causing significant daily impairment. The DSM-5 includes a "performance only" specifier for SAD, but true SAD requires different treatment: CBT and/or SSRIs as first-line, not propranolol PRN alone.
Propranolol is contraindicated in patients with asthma or bronchospasm, significant bradycardia (resting heart rate below 60 bpm), decompensated heart failure, cardiogenic shock, and greater than first-degree heart block. It requires caution in patients with diabetes, COPD, low blood pressure, or Raynaud's phenomenon. Always disclose your full medical history before starting propranolol.
Yes. Propranolol for situational performance anxiety can be prescribed through legitimate telehealth platforms by licensed physicians following a full clinical evaluation. This is an established, appropriate use of telemedicine. Avoid any platform that dispenses medications without a physician assessment — the contraindication screen is clinically necessary, not a formality.
Propranolol works best for the physical dimension — tremor, racing heart, sweating, voice shakiness. It does not address negative self-talk, catastrophizing, or fear of failure. For performers whose anxiety is primarily physical, propranolol alone is often sufficient. For those with significant cognitive anxiety, combining propranolol with CBT or exposure therapy produces better outcomes.
No. For situational performance anxiety, propranolol is taken on an as-needed basis — only before specific events that trigger symptoms. PRN use does not lead to dependence. Daily dosing is a separate clinical scenario used for cardiovascular conditions, not for situational anxiety management.
If physical symptoms are controlled but anxiety remains significantly limiting, adding CBT or exposure therapy targets the cognitive and behavioral dimensions beta-blockers don't address. If the clinical picture actually suggests social anxiety disorder rather than situational anxiety, SSRIs or SNRIs are more appropriate as the foundation of treatment. A physician or mental health professional can help determine the right combination based on your symptom profile.
Propranolol is banned by the World Anti-Doping Agency (WADA) in archery and shooting during competition, where heart rate control provides a direct performance advantage in precision sports. For most other athletic disciplines, it is not on the prohibited list. That said, beta-blockers reduce peak heart rate and exercise capacity, making them impractical for high-intensity sports. Always check current WADA and governing body rules for your sport before use.
It depends on the situation. For discrete, situational performance anxiety — an upcoming speech, audition, or exam — propranolol PRN provides rapid, reliable physical symptom control without the time investment CBT requires. CBT produces more durable change by addressing underlying thought patterns, but it takes weeks to months. For frequent performers or those with significant cognitive anxiety, CBT is worth the investment. For someone with one high-stakes presentation per year, propranolol as needed is often the practical, appropriate choice.
References
- Starcevic V, et al. Propranolol versus Other Selected Drugs in the Treatment of Various Forms of Anxiety and Stress, Including Stage Fright and PTSD. International Journal of Molecular Sciences. 2022 Sep 3; 23(18):10-12. https://pmc.ncbi.nlm.nih.gov/articles/PMC9456064/
- Noguchi K, Bhattarai S. Propranolol. StatPearls. NIH/NCBI Bookshelf. Updated May 2023. https://www.ncbi.nlm.nih.gov/books/NBK557801/
- Substance Abuse and Mental Health Services Administration. Table 16: DSM-IV to DSM-5 Social Phobia/Social Anxiety Disorder Comparison. NBK519712. 2016. https://www.ncbi.nlm.nih.gov/books/NBK519712/table/ch3.t12/
- Strawn JR, Geracioti L, Rajdev N, Clemenza K, Levine A. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry. 2020 Dec 23; 11:595584. https://pmc.ncbi.nlm.nih.gov/articles/PMC7786299/
- Frick A, Gingnell M, et al. Revisiting the SSRI vs. Placebo Debate in the Treatment of Social Anxiety Disorder. Frontiers in Psychology. 2025 May 11. https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2025.1531725/full
- University of Iowa, Carver College of Medicine. Performance Anxiety for Musicians Part 2: Medical Management. Iowa Head and Neck Protocols. 2025. https://iowaprotocols.medicine.uiowa.edu/protocols/performance-anxiety-musicians-part-2-medical-management
- GoodRx Health. 7 Differences Between Propranolol and Xanax for Anxiety. Updated July 2024. https://www.goodrx.com/conditions/generalized-anxiety-disorder/propranolol-vs-xanax